Zunsemetinib
Zunsemetinib (ATI-450) is an orally active and selective inhibitor of the p38α mitogen-activated protein kinase-activated protein kinase 2 (MK2) pathway.Zunsemetinib is used to study spondyloarthritis and rheumatoid arthritis.
Product Specifications
CAS Number
1640282-42-3
Stability
≥ 2 years
Purity
>98% (HPLC)
Weight
513.92
Molecular Formula
C25H22ClF2N5O3
Notes
Research use only, not for human use.
Receptor
MAPK
Available Sizes
Curated Selection
Explore Other Products
Discover premium biology products from our extensive collection of 20M+ items
317096 100 µL
EFG2 (GFM2, EFG2, MSTP027, Ribosome-releasing factor 2, mitochondrial, RRF2mt, Elongation factor G 2, mitochondrial, EF-G2mt, mEF-G 2, Elongation factor G2, hEFG2)
Ask
View Details 